Skip to content
10-Q

Quarterly Report

NANOVIRICIDES, INC. NNVC

0001104659-25-112608

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Nov 14, 2025 18M sh
Shares Diluted Q1 2026 · Sep 30, 2025 17.08M sh
Shares Diluted Q1 2026 · Sep 30, 2024 13.72M sh
Capex Q1 2026 · Sep 30, 2025 $84.32K
Capex Q1 2026 · Sep 30, 2024 $46.76K
Operating Cash Flow Q1 2026 · Sep 30, 2025 −$1.59M
Operating Cash Flow Q1 2026 · Sep 30, 2024 −$2.59M
Cash And Equivalents Q1 2026 · Sep 30, 2025 $1.13M
Cash And Equivalents Q1 2026 · Jun 30, 2025 $1.56M
Stockholders Equity Q1 2026 · Sep 30, 2025 $7.17M
Stockholders Equity Q1 2026 · Jun 30, 2025 $7.52M
Stockholders Equity Q1 2026 · Sep 30, 2024 $10.11M
Stockholders Equity Q1 2026 · Jun 30, 2024 $11.46M
Current Liabilities Q1 2026 · Sep 30, 2025 $1.18M
Current Liabilities Q1 2026 · Jun 30, 2025 $1.31M
Total Liabilities Q1 2026 · Sep 30, 2025 $1.2M
Current Assets Q1 2026 · Sep 30, 2025 $1.25M
Current Assets Q1 2026 · Jun 30, 2025 $1.67M
Total Assets Q1 2026 · Sep 30, 2025 $8.36M
Total Assets Q1 2026 · Jun 30, 2025 $8.82M
Eps Diluted Q1 2026 · Sep 30, 2025 −$0.10
Eps Diluted Q1 2026 · Sep 30, 2024 −$0.23
Eps Basic Q1 2026 · Sep 30, 2025 −$0.10
Eps Basic Q1 2026 · Sep 30, 2024 −$0.23
Sga Expense Q1 2026 · Sep 30, 2025 $803.62K
Sga Expense Q1 2026 · Sep 30, 2024 $1.23M
Rd Expense Q1 2026 · Sep 30, 2025 $993.07K
Rd Expense Q1 2026 · Sep 30, 2024 $1.93M
Net Income Q1 2026 · Sep 30, 2025 −$1.79M
Net Income Q1 2026 · Sep 30, 2024 −$3.13M
Operating Income Q1 2026 · Sep 30, 2025 −$1.8M
Operating Income Q1 2026 · Sep 30, 2024 −$3.17M